In melanoma, CTAs are co-expressed with cell surface HLA class I proteins [60,61,62], which may lead to suppression of cytotoxic T lymphocyte (CTLs) and CD8+ T cells, as well as suppressing NK cell responses [63]. This evidence concerns the gene CD8A and melanoma.